Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.)

Rabe T, Luxembourg B, Ludwig M, Dinger JC, Bauersachs R, Rott H, Mueck AO, Albring C
Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.)
Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2011; 8 (Sonderheft 1): 178-218

Volltext (PDF) Summary Übersicht

Abbildung 9: VTE - OC
VTE risk factors with OC use: VTE risk of drospirenone-containing OCs. Mod. from [9].

Abbildung 9: VTE - OC
VTE risk factors with OC use: VTE risk of drospirenone-containing OCs. Mod. from [9].